Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Sophia Genetics News

Aktie
WKN:  A3CVT8 ISIN:  CH1125843347 US-Symbol:  SOPH Branche:  Gesundheitswesen: Anbieter u. Dienstleister Land:  Schweiz
4,28 €
-0,04 €
-0,93%
09:44:03 Uhr
Depot/Watchlist
Marktkapitalisierung *
271,54 Mio. €
Streubesitz
43,93%
KGV
-3,28
Index-Zuordnung
-

Sophia Genetics News

16.04.26 - PR Newswire
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 PR Newswire
16.04.26 - PR Newswire
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 PR Newswire
03.03.26 - PR Newswire
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results PR Newswire
25.02.26 - PR Newswire
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference PR Newswire
17.02.26 - PR Newswire
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 PR Newswire
10.02.26 - PR Newswire
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems PR Newswire
12.01.26 - PR Newswire
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan PR Newswire
12.01.26 - PR Newswire
SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der Geschäftsführung an
SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der ...
12.01.26 - PR Newswire
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan PR Newswire
07.01.26 - PR Newswire
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology PR Newswire
12.12.25 - PR Newswire
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave PR Newswire
11.11.25 - PR Newswire
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine PR Newswire
11.11.25 - PR Newswire
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine PR Newswire
11.11.25 - PR Newswire
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine PR Newswire
04.11.25 - PR Newswire
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance PR Newswire
21.10.25 - PR Newswire
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 PR Newswire
17.10.25 - PR Newswire
A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben
A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-​Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben PR Newswire
16.10.25 - PR Newswire
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan PR Newswire
16.10.25 - PR Newswire
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
SOPHiA GENETICS Launches AI-​Powered Digital Twins to Enhance Intelligent Decision-​Making in Oncology PR Newswire
23.09.25 - PR Newswire
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy PR Newswire

Newssuche

Videos

newspaper
16.04.26 +0,05%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »